$LXRP check out the 8k - Technology Achieves Cannabidiol Absorption Rate 499% Greater Than Baseline in Laboratory Testing:
LEXARIA CORP ("LXX-Z;LXRP-0") - Technology Achieves Cannabidiol Absorption Rate 499% Greater - Than Baseline in Laboratory Testing
Lexaria, Corp. (the "Company") is very pleased to announce potential industry-changing achievements in enhanced gastro-intestinal absorption of cannabidiol (CBD) utilizing Lexaria's patent pending technology. The recent third-party testing was conducted in two phases of in vitro tests beginning in June and completed in August, 2015.
The independent laboratory results have delivered average CBD permeability of 499% of baseline permeability, compared to CBD permeability without Lexaria's technology. These results exceed Company expectations.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.